Rockwell Medical Technologies, Inc. (RMTI)

Check out top investors' recommendation for RMTI
Last closing price (N/A)
(0.00%) ? 
Last closing price is the stock price upon last market close (date specified in parenthesis).
Return to date (1m/3m/6m/12m):
N/A ? 
Return to date is the stock return for the specified period of time.
Consensus price target (1m/3m/6m/12m):
Consensus price target is the average analyst price target for a specified period of time.
Buy/Sell Mix (1m/3m/6m/12m):
Buy/sell mix the percentage mix between Buy and Sell recommendations for a given company or a research firm. Hold recommendations are excluded.
Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. The company offers products and services for the treatment of end-stage renal disease, chronic kidney disease (CKD), iron deficiency, secondary hyperparathyroidism, and hemodialysis (HD). Its products are used to cleanse patients' blood and replace nutrients lost during the kidney dialysis process. The company manufactures, sells, delivers, and distributes HD concentrates, such as CitraPure citric-acid concentrate, Dri-Sate dry acid, Renal Pure liquid acid concentrate, dry acid concentrate mixing system, RenalPure powder bicarbonate concentrate, and SteriLyte liquid bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, specialized custom kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. It also intends to offer Calcitriol, a generic active vitamin D for the treatment of secondary hyperparathyroidism in dialysis patients. In addition, the company is also developing Soluble Ferric Pyrophosphate, which is in two Phase III clinical trials for iron therapy treatment in CKD-HD patients. Rockwell Medical, Inc. sells its products directly to hemodialysis providers, as well as through independent sales agents and distributors. The company was founded in 1995 and is based in Wixom, Michigan.
An analyst is a professional research analyst or an Investor Wand user who issued a recommendation for a given company.
Research Firm
A Research Firm is a company that researches and rates stocks and publishes recommendations.
Signal is a recommendation issued by an analyst. Investor Wand considers two types of recommendations: BUY and SELL.
Signal Date
A signal date is a date when a BUY or SELL recommendation was issued for given security.
Initial Price
Initial Price is the first closing price for a specified company upon recommendation release. If the recommendation is issued in after-market hours, the Initial Price is the next day’s closing price (for a given symbol). In case of dividend distributions and stock splits, Initial Price is adjusted.
Price Target
A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. It represents the price at which the analyst would exit his or her existing position.
Closing Date
Closing Date is the expiration date of a recommendation. The validity timeframe of a professional analyst’s recommendation is 12 months. Investor Wand analysts can set their recommendation timeframe to one, three, six, or 12 months.
The return on a single open recommendation is calculated as the maximum of the current return (based on the latest closing price) and the target price return, if the symbol reached the target. The return on a single closed recommendation is calculated as the maximum of the return on the closing date (at the end of recommendation timeframe) and the target price return, if the stock hit the target price. The return is adjusted for one-time events (e.g., stock splits).
Ram Selvaraju Aegis Capital Buy   Jun 25, '19     12.00  Jun 25, '20  N/A 
Christopher Raymond Robert W. Baird & Co., Inc. Buy   Jun 24, '19     10.00  Jun 24, '20  N/A 
Jonathan Aschoff Brean Murray, Carret & Co. Sell   Nov 10, '15   10.61  4.00  Nov 10, '16  53.72% 
Ling Wang Summer Street Research Buy   Oct 21, '15   10.61  26.00  Oct 21, '16  -43.07% 
Ling Wang Summer Street Research Buy   Sep 10, '15   11.89  26.00  Sep 10, '16  -40.87% 
Jonathan Aschoff Brean Murray, Carret & Co. Sell   Feb 27, '15   10.00    Feb 27, '16  0.20% 
James Molloy Janney Capital Markets Buy   Jan 27, '15   11.07    Jan 27, '16  -35.77% 
Jonathan Aschoff Brean Murray, Carret & Co. Sell   Jan 26, '15   10.73    Jan 26, '16  29.64% 
Jonathan Aschoff Brean Murray, Carret & Co. Sell   Dec 26, '14   8.61    Dec 26, '15  -23.58% 
Jonathan Aschoff Brean Murray, Carret & Co. Sell   Nov 11, '14   11.15    Nov 11, '15  4.84% 
Jay Martin Unaffiliated Buy   Nov 28, '13   14.63  18.00  Nov 28, '14  -38.41% 
Annabel Samimy Stifel Nicolaus & Company, Inc. Buy   Sep 05, '13   7.99    Sep 05, '14  17.65% 
Carol Werther Summer Street Research Buy   Sep 05, '13   7.99  25.00  Sep 05, '14  17.65% 
Ritu Baral Canaccord Genuity Buy   Feb 06, '13   5.54  15.00  Feb 06, '14  170.76% 
Carol Werther Summer Street Research Buy   Apr 10, '12   8.85  20.00  Apr 10, '13  -56.50% 
Ritu Baral Canaccord Genuity Buy   Jan 02, '12   9.70  14.00  Jan 02, '13  -16.19%